Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Qsymia
Qsymia
Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis
Endpoints
Wed, 07/13/22 - 08:22 pm
Vivus
Qsymia
weight loss
ICER
Novo Nordisk
Saxenda
Wegovy
A decade after its first approval, FDA expands weight loss pill's label for use in adolescents
Endpoints
Tue, 06/28/22 - 10:44 am
Vivus
Qsymia
teens
FDA
obesity
Moving Beyond Obesity, Vivus Strikes $135M Deal for Digestive Drug
Xconomy
Tue, 05/1/18 - 09:54 pm
Vivus
Qsymia
Pancreaze
Janssen
Vivus Announces Positive Ruling In Qsymia Litigation - Will It Matter?
Seeking Alpha
Sat, 07/23/16 - 09:58 am
Vivus
Qsymia
obesity
Vivus: Qsymia Sales Close Out Q2 With Worst Sales Volume In 2 Years
Seeking Alpha
Mon, 07/11/16 - 09:12 am
Vivus
Qsymia
obesity
Vivus - Qsymia Sales Still Trending In The Wrong Direction
Seeking Alpha
Tue, 06/21/16 - 11:19 am
Vivus
Qsymia
obesity
Orexigen struggles to stay afloat as obesity market stagnates
BioPharma Dive
Thu, 05/19/16 - 09:43 am
Orexigen
obesity
Contrave
Vivus
Qsymia
Takeda
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Seeking Alpha
Mon, 05/16/16 - 09:32 pm
Arena Pharmaceuticals
obesity
Orexigen
Belviq
Eisai
Vivus
Novo Nordisk
Qsymia
Victoza
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Fierce Pharma Marketing
Tue, 03/1/16 - 10:56 pm
obesity
Vivus
Orexigen
Contrave
Qsymia
Takeda
Vivus- Were Qsymia Patents Strong Enough? Actavis Stance Questions That
Seeking Alpha
Fri, 02/26/16 - 10:26 pm
Vivus
Qsymia
patents
Actavis
The 3 Most Disappointing Drug Launches of All Time
Motley Fool
Sun, 08/23/15 - 11:49 am
drug launches
MannKind
Afrezza
Sanofi
Zaltrap
Vivus
Arena Pharmaceuticals
Qsymia
Belviq
Can a dwindling rep tally keep Vivus' obesity med in the game?
Fierce Pharma Marketing
Mon, 08/3/15 - 04:52 pm
Vivus
obesity
drug reps
Qsymia
Express Scripts excludes 20 more drugs from 2016 coverage
Yahoo/Reuters
Sat, 08/1/15 - 09:12 am
Express Scripts
formulary
Vivus
Qsymia
AstraZeneca
Onglyza
Lagging Qsymia sales force Vivus to cut sales force again, this time by 50%
Seeking Alpha
Sat, 08/1/15 - 09:01 am
Vivus
Qsymia
layoffs
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Vivus's Products Show Greater Coverage From Top U.S. Health Insurance Providers
Seeking Alpha
Thu, 06/4/15 - 12:07 pm
Vivus
Stendra
Qsymia
insurers
Vivus-Qsymia Sales Post Modest Gain - Slow And Steady Does Not Win The Race
Seeking Alpha
Wed, 06/3/15 - 12:34 pm
Vivus
Qsymia
Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate
Seeking Alpha
Tue, 05/26/15 - 09:57 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Belviq
Contrave
Vivus - Qsymia Script Sales Flat Again - Should Vivus Concentrate On Stendra?
Seeking Alpha
Sat, 05/9/15 - 12:19 pm
Vivus
Qsymia
Stendra
obesity
erectile dysfunction
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia
Yahoo
Tue, 04/21/15 - 05:23 pm
Vivus
Qsymia
patents
Pages
1
2
3
4
5
6
7
8
9
next ›
last »